SUNRISE, Fla., Sept. 10 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that Kristin Comella, Vice President of R&D and Corporate development has been invited to participate in the 2009 World Stem Cell Summit in Baltimore, Maryland, this month.
Ms. Comella will speak on the concurrent panel "Stem Cell Progress Report-Cardiovascular" scheduled for September 23rd from 2:30 to 3:55 PM. The panel will provide an overview for a business, patient and media audience relating to progress in the field. Bioheart will present the business opportunities and challenges. She will join more than 100 expert speakers presenting to an audience of more than 1,200 experts from more than 25 countries.
The 2009 World Stem Cell Summit is being held in Baltimore, Maryland from September 21st - 23rd. Presented by the Genetics Policy Institute, the 2009 Summit is hosted by Johns Hopkins University, the University System of Maryland, Maryland Department of Business and Economic Development, Maryland Technology Development Corporation and Maryland Stem Cell Research Fund. The World Stem Cell Summit is the flagship event, bringing together the founding visionary researchers, clinicians, business pathfinders, key policy-makers, regulators, advocates, experts in law and ethics to present compelling presentations, share information, and together chart the future of regenerative medicine.
About Bioheart, Inc.
Bioheart, Inc. is committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to improve a patient's quality of life and reduce health care costs and hospitalizations. Specific to biotechnology, Bioheart is focused on
|SOURCE Bioheart, Inc.|
Copyright©2009 PR Newswire.
All rights reserved